In situ recognition of autoantigen as an essential gatekeeper in autoimmune CD8+ T cell inflammation - PubMed (original) (raw)
In situ recognition of autoantigen as an essential gatekeeper in autoimmune CD8+ T cell inflammation
Jinguo Wang et al. Proc Natl Acad Sci U S A. 2010.
Abstract
A current paradigm states that non-antigen-specific inflammatory cues attract noncognate, bystander T cell specificities to sites of infection and autoimmune inflammation. Here we show that cues emanating from a tissue undergoing spontaneous autoimmune inflammation cannot recruit naive or activated bystander T cell specificities in the absence of local expression of cognate antigen. We monitored the recruitment of CD8(+) T cells specific for the prevalent diabetogenic epitope islet-specific glucose-6-phosphatase catalytic subunit-related protein (IGRP)(206-214) in gene-targeted nonobese diabetic (NOD) mice expressing a T cell "invisible" IGRP(206-214) sequence. These mice developed islet inflammation and diabetes with normal incidence and kinetics, but their inflammatory lesions could recruit neither naive (endogenous or exogenous) nor ex vivo-activated IGRP(206-214)-reactive CD8(+) T cells. Conversely, IGRP(206-214)-reactive, but not nonautoreactive CD8(+) T cells rapidly homed to and accumulated in the inflamed islets of wild-type NOD mice. Our results indicate that CD8(+) T cell recruitment to a site of autoimmune inflammation results from an active process that is strictly dependent on local display of cognate pMHC and suggest that CD8(+) T cells contained in extralymphoid autoimmune lesions are largely autoreactive.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Fig. 1.
NOD.IGRPK209A/F213A KI/KI mice develop insulitis and diabetes without recruiting IGRP206–214-reactive CD8+ T cells into pancreatic islets. (A) Targeting strategy. The FRT-flanked PGK-neo cassette was removed from targeted ES cells by transient transfection of Flp recombinase-encoding cDNA. (B) Distribution of lymphocyte subsets in thymi and spleens from NOD and NOD.IGRPK209A/F213A KI/KI mice (n = 3 and 5, respectively; 3 independent experiments). DN, double negative; DP, double positive; CD8-SP, CD8 single positive; CD4-SP, CD4 single positive. (C) Frequency of NRP-V7–reactive CD8+ T cells in peripheral blood. Peripheral blood mononuclear cells (PBMCs) from 10-week-old mice (NOD, n = 7; NOD.IGRPK209A/F213A KI/KI, n = 8) were stained with NRP-V7/Kd tetramers and anti-CD8 mAb. Data correspond to 4 independent experiments using one to five mice/experiment. (D) Insulitis scores. Pancreata from nondiabetic 32-week-old mice (NOD, n = 3; NOD.IGRPK209A/F213A KI/KI, n = 5) were examined for islet inflammation. Pancreata were from one cohort of NOD mice and two different cohorts of NOD.IGRPK209A/F213A KI/KI mice. (E and F) CD4+ and CD8+ T cell (E) and NRP-V7/Kd tetramer+ CD8+ T cell content (F) in freshly isolated islets of NOD (n = 6; 3 independent experiments) vs. NOD.IGRPK209A/F213A KI/KI mice (n = 7; 4 independent experiments). (G) Absence of IGRP206–214 -reactive CD8+ T cells in the islet infiltrates of NOD.IGRPK209A/F213A KI/KI (n = 10; 10 independent experiments) vs. NOD mice (n = 3; 3 independent experiments). Islet-associated CD8+ T cells were cultured in IL-2 for 7 days and challenged with peptide-pulsed (10 μM) irradiated NOD splenocytes. The IFNγ content in the supernatants (at 48 h) was measured by ELISA. Data correspond to the means ± SEM. (H) Diabetes incidence in female NOD (n = 56) and NOD.IGRPK209A/F213A KI/KI (n = 27) mice. The average blood glucose levels in newly diagnosed diabetic NOD and NOD.IGRPK209A/F213A KI/KI mice are: 22.3 ± 2.5 vs. 23.7 ± 3.3 mM, respectively. In males, the incidence and average age at onset of disease were also similar in both strains (NOD: n = 15; 40% diabetic at 133 ± 33 days; and NOD.IGRPK209A/F213A KI/KI: n = 20; 50% diabetic at 149 ± 36 days). Data in B_–_F correspond to the means ± SEM. P values in F and G were obtained with Mann-Whitney _U_-test.
Fig. 2.
Naive 8.3-CD8+ T cells are not recruited into the inflamed pancreatic islets of NOD.IGRPK209A/F213A KI/KI mice. (A) Proliferation of naive 8.3-CD8+ T cells in the PLN. CFSE-labeled naive 8.3-CD8+ T cells were transfused into 10- to 12-week-old NOD (n = 3) or NOD.IGRPK209A/F213A KI/KI (n = 3) recipients (three independent experiments, each using both host types). Dilution of CFSE was measured by flow cytometry 7 days posttransfer. Values correspond to the average percentage of proliferated CD8+ T cells ± SEM. (B) Summary of data described in A. P values were obtained with Mann-Whitney _U_-test. (C) Recruitment and proliferation of naive 8.3-CD8+ T cells from 8.3-NOD.Thy1.1 donor mice in the lymphoid organs and islets of 10- to 12-week-old insulitic NOD and NOD.IGRPK209A/F213A KI/KI hosts 1, 2, and 3 weeks after transfer. CFSE histograms correspond to Thy1.1+CD8+ cells. (D) Mean ± SEM of total numbers of 8.3-CD8+ T cells per million lymphocytes. Data in C and D correspond to three to six experiments/time point and host type (one mouse/time point/host in each experiment). (E) Mean ± SEM of percentages of proliferated cells (for PLNs) or total number of donor lymphocytes (for islet T cell isolates, where all donor-derived T cells were proliferating) (three to six experiments/time point and host type; one mouse/time point/host in each experiment). (F) Absolute numbers of proliferated (for PLNs) or recruited (for islet T cell isolates) 8.3-CD8+ T cells (mean ± SEM) (three to six experiments/time point and host type; one mouse/time point/host in each experiment). P values in D_–_F were obtained by two-way ANOVA.
Fig. 3.
Selective recruitment of cognate autoreactive T cells into pancreatic islets of NOD mice. (A) Naive 8.3-CD8+/Thy1.2+ and P14-CD8+/Thy1.2+ T cells were mixed at 1:1 (8 × 106 cells each) and injected i.v. into 10- to 12-week-old NOD.Thy1.1 hosts. Hosts were killed at various time points after transfer and their peripheral lymphoid organs and islet cell suspensions analyzed for presence of NRP-V7/Kd and GP33/Db tetramer+ Thy1.2+ CD8+ T cells. Data correspond to three mice/time point (n = 12 mice) and three independent experiments (one mouse/time point in each experiment) and are shown as mean ± SEM. (B) Data from A presented as absolute numbers of cells (mean ± SEM). P values were obtained with two-way ANOVA.
Fig. 4.
The pancreatic islets of NOD.IGRPK209A/F213A KI/KI mice also fail to recruit activated 8.3-CD8+ T cells, even when inflamed. (A) In vitro-activated, CFSE-labeled 8.3-CD8+ T cells were injected i.v. into 3-week-old NOD or NOD.IGRPK209A/F213A KI/KI hosts. Pancreatic sections were stained with anti-insulin antibodies and examined for presence of CFSE+ T cells by confocal microscopy on days 1 and 3 after transfer (three mice/time point; 10–20 islets/mouse; three independent experiments). Representative images are shown. An adjacent tissue section was stained with H&E (Left). (White scale bars, 20 μm.) On NOD hosts’ day 1 samples, CFSE+ T cells were predominantly found in the peri-insular space. Note the near complete depletion of insulin+ cells in the CFSE+ T cell-containing areas of NOD hosts’ day 3 samples. (B) Incidence of diabetes in 3-week-old NOD (n = 7) or NOD.IGRPK209A/F213A KI/KI recipients (n = 6) of 8.3-CTL (two independent experiments, each including three to four mice/strain type). P values were obtained with log rank test. (C) In vitro-activated, CFSE-labeled 8.3-CD8+ Thy1.1+ T cells were injected i.v. into 10- to 12-week-old NOD or NOD.IGRPK209A/F213A KI/KI hosts. Hosts were analyzed for presence of Thy1.1+ CD8+ T cells in different organs. Data correspond to three to four independent experiments/time point and strain (one mouse/time point/strain in each experiment) and are shown as mean ± SEM. (D) Data from C presented as absolute numbers of cells per million lymphocytes (mean ± SEM). P values in C and D were obtained with two-way ANOVA. (E) Analysis of pancreas sections from 10- to 12-week-old mice transfused with CFSE-labeled in vitro-activated 8.3-CD8+ T cells on days 1 and 3 after transfer, for presence of CFSE+ T cells (three independent experiments; one mouse/time point/strain in each experiment). Images of islets are representative of severe insulitis.
Similar articles
- Local autoantigen expression as essential gatekeeper of memory T-cell recruitment to islet grafts in diabetic hosts.
Alkemade GM, Clemente-Casares X, Yu Z, Xu BY, Wang J, Tsai S, Wright JR Jr, Roep BO, Santamaria P. Alkemade GM, et al. Diabetes. 2013 Mar;62(3):905-11. doi: 10.2337/db12-0600. Epub 2012 Nov 16. Diabetes. 2013. PMID: 23160528 Free PMC article. - Early autoimmune destruction of islet grafts is associated with a restricted repertoire of IGRP-specific CD8+ T cells in diabetic nonobese diabetic mice.
Wong CP, Li L, Frelinger JA, Tisch R. Wong CP, et al. J Immunol. 2006 Feb 1;176(3):1637-44. doi: 10.4049/jimmunol.176.3.1637. J Immunol. 2006. PMID: 16424193 - Genetic and therapeutic control of diabetogenic CD8+ T cells.
Santamaria P. Santamaria P. Novartis Found Symp. 2008;292:130-6; discussion 136-45, 202-3. doi: 10.1002/9780470697405.ch12. Novartis Found Symp. 2008. PMID: 19209463 - Deleting islet autoimmunity.
Liu E, Li M, Jasinski J, Kobayashi M, Gianani R, Nakayama M, Eisenbarth GS. Liu E, et al. Cell Biochem Biophys. 2007;48(2-3):177-82. doi: 10.1007/s12013-007-0022-9. Cell Biochem Biophys. 2007. PMID: 17709887 Review. - Kinetic evolution of a diabetogenic CD8+ T cell response.
Santamaria P. Santamaria P. Ann N Y Acad Sci. 2003 Nov;1005:88-97. doi: 10.1196/annals.1288.010. Ann N Y Acad Sci. 2003. PMID: 14679043 Review.
Cited by
- Immunopeptidome mining reveals a novel ERS-induced target in T1D.
Wang L, Yang S, Zhu G, Li J, Meng G, Chen X, Zhang M, Wang S, Li X, Pan Y, Huang Y, Wang L, Wu Y. Wang L, et al. Cell Mol Immunol. 2024 Jun;21(6):604-619. doi: 10.1038/s41423-024-01150-0. Epub 2024 Apr 30. Cell Mol Immunol. 2024. PMID: 38689020 - The beta cell-immune cell interface in type 1 diabetes (T1D).
James EA, Joglekar AV, Linnemann AK, Russ HA, Kent SC. James EA, et al. Mol Metab. 2023 Dec;78:101809. doi: 10.1016/j.molmet.2023.101809. Epub 2023 Sep 20. Mol Metab. 2023. PMID: 37734713 Free PMC article. Review. - Monitoring immunomodulation strategies in type 1 diabetes.
Krishnamurthy B, Lacorcia M, Kay TWH, Thomas HE, Mannering SI. Krishnamurthy B, et al. Front Immunol. 2023 Jun 6;14:1206874. doi: 10.3389/fimmu.2023.1206874. eCollection 2023. Front Immunol. 2023. PMID: 37346035 Free PMC article. Review. - Engineering the lymph node environment promotes antigen-specific efficacy in type 1 diabetes and islet transplantation.
Gammon JM, Carey ST, Saxena V, Eppler HB, Tsai SJ, Paluskievicz C, Xiong Y, Li L, Ackun-Farmmer M, Tostanoski LH, Gosselin EA, Yanes AA, Zeng X, Oakes RS, Bromberg JS, Jewell CM. Gammon JM, et al. Nat Commun. 2023 Feb 8;14(1):681. doi: 10.1038/s41467-023-36225-5. Nat Commun. 2023. PMID: 36755035 Free PMC article. - Identification of an Autoantibody Against ErbB-3-Binding Protein-1 in the Sera of Patients With Chronic Hepatitis B Virus Infection.
Jiang L, Niu W, Zheng Q, Meng G, Chen X, Zhang M, Deng G, Mao Q, Wang L. Jiang L, et al. Front Immunol. 2021 May 25;12:640335. doi: 10.3389/fimmu.2021.640335. eCollection 2021. Front Immunol. 2021. PMID: 34113340 Free PMC article.
References
- von Andrian UH, Mackay CR. T-cell function and migration. Two sides of the same coin. N Engl J Med. 2000;343:1020–1034. - PubMed
- Mora JR, von Andrian UH. T-cell homing specificity and plasticity: New concepts and future challenges. Trends Immunol. 2006;27:235–243. - PubMed
- Stephens R, Randolph DA, Huang G, Holtzman MJ, Chaplin DD. Antigen-nonspecific recruitment of Th2 cells to the lung as a mechanism for viral infection-induced allergic asthma. J Immunol. 2002;169:5458–5467. - PubMed
- Ostler T, Pircher H, Ehl S. “Bystander” recruitment of systemic memory T cells delays the immune response to respiratory virus infection. Eur J Immunol. 2003;33:1839–1848. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials